Could Roivant Sciences Be a Multibagger Stock Soon
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
Which Credit Cards Have The Best Rewards And No Fees
Identify credit cards that provide excellent rewards without any fees. Get the most out of your spending.
28,070 articlesWill Bitcoin Drop $50,000 as Strategy Sells BTC Moves?
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
Lumen Technologies Stock Sell: Is It a Buy After Insider Dump?
A director sold 45,000 LUMN shares, triggering questions about Lumen Technologies stock sell signals. This article br...
Cramer: SK Hynix Mispricing in Korea, AI Memory Bullish
Jim Cramer argues that South Korea mispricing SK Hynix reflects trader psychology rather than weak fundamentals. He r...
If Now, There Would Be a Trade-First Path Forward Today
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
Upstart Plunged February: Key Drivers Behind the Selloff
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
Nvidia's Billion Groq Acquisition Could Change AI Inference
Nvidia pulls off a landmark $20B Groq deal that could reshape AI inference in 2026. This piece breaks down the tech, ...
This Arguably Most Important Update for Stock Investors
A sweeping market update is arriving just as tech stocks face a new mix of opportunities and risks. This arguably mos...
Warren Buffett Greg Abel Spent $78B Buying This Stock Since 2018
What would it look like if a legendary duo concentrated nearly $80 billion into one stock? This thought-provoking pie...
Erasca CMO's Direct Stake Goes to Zero: Investor Implications
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
Anheuser-Busch Still Even Though People Drink Less—A Buy Case
Even as global drinking declines, Anheuser-Busch InBev shows resilience through a diversified brand mix, cost discipl...
After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Time To Notice Score Change After Secured Card
Secured Card Reported To Credit Bureaus Instantly